| - Industry | - Sector | - CEO | XFRA Exchange | - ISIN |
| Germany Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
LEO INTERNATIONAL PRECISION HEALTH AG, often referred to as Leo International Precision Health AG, is a small healthcare-technology firm located in the Munich area of Germany. The company is publicly traded on the Frankfurt Stock Exchange under the symbol LEOW, among other related ticker codes. Leo International focuses primarily on the healthcare technology sector, specifically targeting precision health and medical technology solutions and services as opposed to traditional pharmaceutical manufacturing, which distinguishes it within the broader healthcare landscape.
The company’s registered office can be found in Garching bei München, placing it within a prominent ecosystem for life sciences and technological innovation in Germany. The organizational structure of the company adheres to the German stock-corporation (AG) law, featuring a supervisory board typical for publicly listed entities in Germany.
Leo International Precision Health AG has its roots connected to SPOBAG AG, a previously established Munich-based company that had limited operational activities before repositioning itself towards precision health. This evolution reflects an adaptive strategy in the rapidly changing healthcare technology arena. As a small-cap and specialized issuer, the firm may face limitations in terms of liquidity, research coverage, and financial disclosure compared to larger healthcare companies listed in Frankfurt. Investors are encouraged to examine official investor relations materials, company filings, and current trading data before making any decisions.
The company offers tailored solutions designed to enhance health outcomes by utilizing advanced data analytics, allowing for personalized treatment and proactive medical interventions. These solutions leverage technology to facilitate patient-specific data management, ensuring that treatments and health advice are optimized for individual needs.
Leo International provides a range of medical technology services aimed at improving clinical operations and patient care. These services include the development and deployment of medical devices and support systems that enhance diagnosis, treatment efficacy, and patient monitoring. The focus is on integrating innovative technology into everyday healthcare practices.
Offering advanced data analytics and management services, Leo International aids healthcare providers in making informed decisions based on comprehensive data sets. Their analytics platforms are designed to synthesize vast amounts of health-related data, enabling better resource allocation and improving overall healthcare delivery.
The company engages in research and development endeavors to foster innovation in precision health and medical technologies. This includes partnerships with academic institutions and other research organizations to advance the science of personalized medicine and health tech solutions.
Leo International offers consulting services to assist healthcare institutions in transitioning to precision health models. These services encompass strategic planning, implementation of cutting-edge technologies, and training for staff to adapt to new systems and protocols that improve patient care.